Mcleod Russel India Ltd
Incorporated in 1998, McLeod Russel
India Ltd is in the business of cultivation
and manufacturing of tea[1]
- Market Cap ₹ 412 Cr.
- Current Price ₹ 39.4
- High / Low ₹ 68.7 / 27.6
- Stock P/E
- Book Value ₹ 6.08
- Dividend Yield 0.00 %
- ROCE -1.85 %
- ROE -142 %
- Face Value ₹ 5.00
Pros
Cons
- Stock is trading at 6.53 times its book value
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of 0.73% over past five years.
- Promoter holding is low: 6.24%
- Company has a low return on equity of -39.3% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1,789 | 1,646 | 1,926 | 1,871 | 2,055 | 1,723 | 1,143 | 1,438 | 1,356 | 1,370 | 1,136 | 1,185 | 1,190 | |
| 1,436 | 1,516 | 1,754 | 1,761 | 1,903 | 1,763 | 1,101 | 1,243 | 1,288 | 1,275 | 1,245 | 1,164 | 1,201 | |
| Operating Profit | 353 | 130 | 172 | 110 | 152 | -41 | 42 | 195 | 68 | 95 | -109 | 21 | -12 |
| OPM % | 20% | 8% | 9% | 6% | 7% | -2% | 4% | 14% | 5% | 7% | -10% | 2% | -1% |
| 42 | 43 | 88 | 184 | 382 | 523 | 73 | 20 | 10 | -918 | 17 | 22 | 4 | |
| Interest | 60 | 72 | 109 | 136 | 180 | 338 | 227 | 205 | 165 | 201 | 203 | 226 | 204 |
| Depreciation | 38 | 77 | 102 | 104 | 102 | 84 | 78 | 90 | 75 | 70 | 66 | 61 | 61 |
| Profit before tax | 297 | 25 | 49 | 55 | 252 | 61 | -189 | -80 | -162 | -1,093 | -362 | -245 | -272 |
| Tax % | 12% | -38% | 29% | -18% | 13% | 36% | -22% | -34% | 12% | -3% | -14% | -19% | |
| 261 | 33 | 35 | 64 | 219 | 39 | -148 | -52 | -181 | -1,057 | -312 | -198 | -225 | |
| EPS in Rs | 23.49 | 2.85 | 2.56 | 5.35 | 19.00 | 3.05 | -14.15 | -5.02 | -17.32 | -101.14 | -29.83 | -18.94 | -21.57 |
| Dividend Payout % | 30% | 105% | 59% | 4% | 2% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -3% |
| 5 Years: | 1% |
| 3 Years: | -4% |
| TTM: | -2% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | -3% |
| 3 Years: | -7% |
| TTM: | 14% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | -13% |
| 5 Years: | 12% |
| 3 Years: | 31% |
| 1 Year: | 35% |
| Return on Equity | |
|---|---|
| 10 Years: | -7% |
| 5 Years: | -17% |
| 3 Years: | -39% |
| Last Year: | -142% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 55 | 55 | 41 | 41 | 46 | 44 | 52 | 52 | 52 | 52 | 52 | 52 | 52 |
| Reserves | 2,102 | 2,037 | 1,909 | 1,918 | 2,121 | 1,971 | 1,802 | 1,771 | 1,596 | 517 | 198 | 4 | 11 |
| 304 | 602 | 836 | 936 | 1,091 | 1,812 | 2,346 | 2,261 | 2,089 | 1,961 | 1,892 | 1,902 | 1,911 | |
| 427 | 395 | 604 | 557 | 585 | 733 | 735 | 824 | 1,025 | 1,209 | 1,394 | 1,636 | 1,782 | |
| Total Liabilities | 2,888 | 3,089 | 3,390 | 3,452 | 3,843 | 4,559 | 4,935 | 4,908 | 4,763 | 3,740 | 3,536 | 3,594 | 3,756 |
| 2,073 | 2,165 | 2,164 | 2,137 | 2,120 | 1,475 | 1,426 | 1,397 | 1,395 | 1,386 | 1,280 | 1,260 | 1,244 | |
| CWIP | 53 | 63 | 96 | 91 | 107 | 89 | 93 | 67 | 56 | 47 | 45 | 41 | 47 |
| Investments | 13 | 12 | 78 | 72 | 96 | 101 | 11 | 53 | 62 | 52 | 62 | 58 | 70 |
| 749 | 848 | 1,051 | 1,151 | 1,520 | 2,893 | 3,406 | 3,391 | 3,250 | 2,254 | 2,148 | 2,234 | 2,395 | |
| Total Assets | 2,888 | 3,089 | 3,390 | 3,452 | 3,843 | 4,559 | 4,935 | 4,908 | 4,763 | 3,740 | 3,536 | 3,594 | 3,756 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 197 | 108 | 207 | 137 | 196 | 280 | 84 | 178 | 105 | 205 | 34 | 72 | |
| -135 | -271 | -289 | -68 | -147 | -323 | -740 | -1 | -57 | -42 | 57 | -19 | |
| -60 | 159 | 85 | -64 | -28 | 320 | 362 | -132 | -120 | -174 | -100 | -50 | |
| Net Cash Flow | 2 | -5 | 3 | 5 | 21 | 277 | -295 | 45 | -72 | -11 | -9 | 3 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 10 | 19 | 24 | 21 | 22 | 8 | 11 | 8 | 13 | 11 | 15 | 15 |
| Inventory Days | 281 | 354 | 244 | 274 | 251 | 275 | 486 | 352 | 288 | 422 | 343 | |
| Days Payable | 101 | 169 | 132 | 135 | 136 | 212 | 223 | 192 | 204 | 349 | 345 | |
| Cash Conversion Cycle | 189 | 204 | 135 | 161 | 137 | 71 | 273 | 168 | 97 | 84 | 13 | 15 |
| Working Capital Days | -14 | 0 | 14 | 7 | 58 | -345 | -734 | -624 | -661 | -708 | -933 | -938 |
| ROCE % | 15% | 4% | 6% | 6% | 8% | 3% | -0% | 3% | 0% | 1% | -7% | -2% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
19 Feb - Copies Newspaper Advertisement(s) of Notice regarding Special Window for Re-lodgement of Transfer Requests and Dematerialisation of Physical Shares.
- Announcement under Regulation 30 (LODR)-Newspaper Publication 14 Feb
-
Unaudited Financial Results For Quarter Ended 31.12.2025
13 Feb - Approved unaudited results for quarter/nine months ended Dec 31, 2025; auditors flagged going-concern, ICDs Rs.2,76,109 lakhs
-
Board Meeting Outcome for Unaudited Financial Results, Both On Standalone And Consolidated Basis, For Quarter And Nine Months Ended On 31St December, 2025.
13 Feb - Unaudited Q3/9M results approved; auditor adverse review cites Rs.2,86,050 lakh ICDs, going-concern uncertainty and large debt exposure.
-
Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results, Both On Standalone And Consolidated Basis, For Quarter And Nine Months Ended On 31St December, 2025.
6 Feb - Board meeting on 13 Feb 2026 to approve Q3/9M unaudited results ended 31 Dec 2025; trading window remains closed.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Business Overview:[1][2]
MLRL is a tea plantation company of Kolkata-based B.M. Khaitan Group and was formed
after the demerger of the bulk tea business from Eveready Industries India Ltd. It is in the business of cultivation, manufacture, and sale
of tea and is managed as a single-unit organization.